Skip to main content
OpenTrials

Clinical trial condition

Metastatic Prostate Cancer

Explore clinical trials studying Metastatic Prostate Cancer. Study availability and eligibility vary by location and protocol.

136 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Prostate Cancer trial results

Active, Not Recruiting

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

NCT04262154

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +43 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Northwestern Medicine Cancer Centers Warrenville, Illinois, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Active, Not Recruiting

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

NCT02051218

Conditions
Bone Metastases, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • Klinikum Wels-Grieskrichen GmbH Wels, Austria
  • Uniklinik Düsseldorf, Urologische Klinik Düsseldorf, Germany
  • Universitätsklinikum Düsseldorf, Frauenheilkunde/Geburtshilfe Düsseldorf, Germany
View all 50 locations
View Trial Details
Active, Not Recruiting

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

NCT04446117

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Exelixis Clinical Site #4 Tucson, Arizona, United States
  • Exelixis Clinical Site #42 Duarte, California, United States
  • Exelixis Clinical Site #2 Fullerton, California, United States
  • Exelixis Clinical Site #224 La Jolla, California, United States
View all 280 locations
View Trial Details

Related conditions